34,739 results on '"Pancreatic neoplasms"'
Search Results
2. Patent Issued for Kit or device for detecting early stage pancreatic cancer or pancreatic cancer precursor lesions and detection method therefor (USPTO 12098430).
3. Patent Issued for Use of bispecific antigen-binding molecules that bind MUC16 and CD3 in combination with 4-1BB co-stimulation (USPTO 12091460).
4. Patent Issued for Conjugated biological molecules, pharmaceutical compositions and methods (USPTO 12090212).
5. Findings from AntiCancer Inc. Broaden Understanding of Pancreatic Cancer (First-line Chemotherapy In Combination With Oral Recombinant Methioninase and a Low-methionine Diet for a Stage Iv Inoperable Pancreatic-cancer Patient Resulted In 40%...).
6. Patent Issued for Substituted piperazines as KRAS G12C inhibitors (USPTO 12083121).
7. Patent Issued for Conjoint therapies for immunomodulation (USPTO 12064418).
8. Old chemo drug, new pancreatic cancer therapy?
9. New Findings from Cancer Center in the Area of Pancreatic Cancer Described (Intratumoral Nkt Cell Accumulation Promotes Antitumor Immunity In Pancreatic Cancer).
10. Research from Health Research Inc. Provides New Study Findings on Pancreatic Cancer (Anakinra-Loaded Sphingomyelin Nanosystems Modulate In Vitro IL-1-Dependent Pro-Tumor Inflammation in Pancreatic Cancer).
11. Patent Issued for HDAC inhibitors and therapeutic use thereof (USPTO 12043607).
12. Patent Issued for Endoscopic cryoablation catheter (USPTO 12042203).
13. Patent Issued for Combination therapy (USPTO 12036227).
14. Patent Application Titled "Il-13ralpha2 Targeted Immunotoxins And Methods Of Use" Published Online (USPTO 20240239857).
15. Sirnaomics Announces Completion of STP707 Phase I Clinical Study with Strong Safety Profile and Disease Activity for the Treatment of Pancreatic Cancer Patients.
16. Patent Issued for Method of modulating TIGIT and PD-1 signalling pathways using 1,2,4-oxadiazole compounds (USPTO 12005045).
17. Pancreatic cancer's cellular amnesia.
18. Patent Issued for Human mesothelin chimeric antigen receptors and uses thereof (USPTO 11999794).
19. Synergistic cytotoxicity of HDAC and PARP inhibitors and decitabine in pancreatic cancer cells: implications for novel therapy.
20. Researchers Submit Patent Application, "Method And Kit For Assisting In Determination Of Malignant Pancreatic Cystic Tumor", for Approval (USPTO 20240168026).
21. Patent Issued for 17a-monoesters and 17a,21-diesters of cortexolone for use in the treatment of tumors (USPTO 11986484).
22. "Methods Of Treating Pancreatic Cancer" in Patent Application Approval Process (USPTO 20240165071).
23. SRI earns FDA Orphan Drug Designation for pancreatic cancer.
24. Oncolytics Biotech(R) Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer.
25. Patent Issued for Method of examining possibility of subject having pancreatic cancer (USPTO 11965887).
26. New Pancreatic Cancer Data Have Been Reported by Investigators at Merck & Company (Modeling Health Outcomes Associated With Brca Testing and Treatment Strategies for Patients With Metastatic Pancreatic Cancer).
27. Symptomatic pancreatic body endometrial cyst requiring en bloc distal pancreatectomy
28. Imaging diagnosis of autoimmune pancreatitis: computed tomography and magnetic resonance imaging
29. Contemporary clinical trials in pancreatic cancer immunotherapy targeting PD-1 and PD-L1
30. A comprehensive review of the multifaceted role of the microbiota in human pancreatic carcinoma
31. Researchers Submit Patent Application, "Image Processing Apparatus, Image Processing Method, And Image Processing Program", for Approval (USPTO 20240112786).
32. Patent Issued for Combination therapy including a KRASG12C inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers (USPTO 11918584).
33. Oncolytics Biotech(R) Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN.
34. Groundbreaking New Blood Test Offers Early Pancreatic Cancer Diagnosis Study Says.
35. Pancreatic cancer lives on mucus.
36. Patent Application Titled "Non-Invasive Methods Of Detecting Target Molecules" Published Online (USPTO 20240041438).
37. Pancreatic cancer hijacks a brain-building protein.
38. Patent Issued for Systems and methods for treatment of pancreatic cancer (USPTO 11883655).
39. FDA Grants Orphan Drug Designation ODD Status to NeoImmuneTech's NT-I7 for Advanced Pancreatic Cancer Treatment.
40. Researchers Submit Patent Application, "Medical Image Processing Device, Operation Method Of Medical Image Processing Device, And Operation Program Of Medical Image Processing Device", for Approval (USPTO 20240020838).
41. Research Reports on Pancreatic Cancer from Foundation Medicine Inc. Provide New Insights [Relationship of tumor fraction in circulating tumor DNA (ctDNA) with prognosis in patients with metastatic pancreatic cancer].
42. Locally advanced pancreatic cancer: a reliable contraindication to resection in the modern era?
43. Does race affect the long-term survival benefit of systemic therapy in pancreatic adenocarcinoma?
44. Multi-Center Follow-up Study to Develop a Classification System Which Differentiates Mucinous Cystic Neoplasm of the Liver and Benign Hepatic Cyst Using Machine Learning
45. Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer
46. Alternative cause for hypoglycaemia in insulin-treated diabetes mellitus
47. Giant retroperitoneal lymph node-an uncommon presentation of duodenal neuroendocrine tumour
48. Case report of a pancreatic insulinoma misdiagnosed as epilepsy
49. Technical aspects in pancreaticoduodenectomy and therapeutic strategies for pancreatic cancer: History, current status, and future perspectives
50. Pancreatic Adenocarcinoma: Diagnostic Errors, Contributing Factors and Solutions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.